Healthcare -
Biotechnology - NASDAQ - US
$ 29.55
1.41 %
$ 4.6 B
Market Cap
-295.5
P/E
TGTX - TOTAL CURRENT LIABILITIES
Total Current Liabilities TGTX - TG Therapeutics, Inc.
53.7 M
LAST VALUE
-9.36%
2 YEAR CAGR
6.69%
5 YEAR CAGR
23.87%
10 YEAR CAGR